Ronald J. Manning
Ronald G. Manning, Ph.D. is the founder and principal at RGM Chemistry Consulting, LLC, Santa Rosa, CA, where he advises clients regarding their overall strategy as they progress toward an Animal Rule clinical indication. Dr. Manning has deep personal in the field of developing Chemical, Radiological and Nuclear (CRN) medical countermeasures (including diagnostics). He provides expert advice on communications with government agencies such as BARDA, NIH, FDA, CDC, and DOD. Dr. Manning provides recommendations regarding the design of animal efficacy studies and development of animal models.
Dr. Manning was most currently the Senior Technical Director, SNBL USA, Everett, where he was responsible for meeting SNBL performance metrics in three general programmatic areas: (1) animal model development and testing of drugs used to treat radiation exposures related to radiological or nuclear (Rad/Nuc) incidents, (2) animal model development and testing of products used to treat radiation exposures related to clinical procedures (e.g., oncology), and (3) U.S. Government (USG) contracts related to any SNBL capability. Under his direction, SNBL successfully launched its Rad/Nuc program in 2015. Accomplishments included several commercial contracts, and also awards from the Government, including a contract to assist in the animal model development of medical countermeasures.
Prior to SNBL, Dr. Manning was a Supervisory Interdisciplinary Scientist; Chemical, Radiological and Nuclear (CRN) Medical Countermeasures (MCMs); Division of Chemical, Biological, Radiological and Nuclear (CBRN) Medical Countermeasures; Biomedical Advanced Research and Development Authority (BARDA); Office of the Assistant Secretary for Preparedness and Response (ASPR); Department of Health and Human Services, Washington, DC where his duties were to develop and manage a portfolio of projects which result in the development of medical countermeasures (MCMs) against chemical, radiological and nuclear (CRN) threats. He was the CRN Branch Chief, supervising 15 staff.
Prior to his work at HHS, Dr. Manning was a Vice President with the United States Pharmacopeial Convention, Inc., (USP) Rockville, MD
Dr. Manning received his B.S. in Chemistry and Ph.D. in Chemistry from the University of California, Davis. He is an author on more than 60 peer reviewed publications.